The 20 Best Radiation Sickness Doctors Near Me in Ann Arbor, MI
Find the Top Radiation Sickness Experts and Specialists
MediFind found 9 doctor with experience in Radiation Sickness near Ann Arbor, MI. Of these, 9 are Experienced.
U Of M Radiology
Perry Pernicano is a Radiologist in Ann Arbor, Michigan. Dr. Pernicano is rated as an Experienced provider by MediFind in the treatment of Radiation Sickness. His top areas of expertise are Chronic Cough, Synovial Sarcoma, Lung Nodules, and Cystic Fibrosis.
U Of M Radiology
Eric Liao is a Radiologist and a Neuroradiologist in Ann Arbor, Michigan. Dr. Liao is rated as an Experienced provider by MediFind in the treatment of Radiation Sickness. His top areas of expertise are Meningioma, Pediatric Low-Grade Glioma (pLGG), Arachnoid Cysts, and Neurofibromatosis Type 2 (NF2).
University Of Michigan Medical Center
Chiemezie Amadi is a Radiologist in Ann Arbor, Michigan. Dr. Amadi has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Radiation Sickness. His top areas of expertise are Pleurisy, Pleural Effusion, Lung Nodules, and ALK-Positive Non-Small Cell Lung Cancer.
Frankel Cardiovascular Center
Andrea Obi is a General Surgeon and a Vascular Surgeon in Ann Arbor, Michigan. Dr. Obi is rated as an Experienced provider by MediFind in the treatment of Radiation Sickness. Her top areas of expertise are Idiopathic Edema, Stasis Dermatitis and Ulcers, Venous Insufficiency, and Deep Vein Thrombosis.
Frankel Cardiovascular Center
Jonathan L. Eliason, M.D., is the S. Martin Lindenauer Collegiate Professor of Vascular Surgery. Dr. Eliason received his undergraduate degree from Bethel College in St. Paul, Minnesota and his medical degree from the University of Minnesota Medical School. He then relocated to Nashville, Tennessee where he completed his General Surgery Residency at Vanderbilt University Medical Center. He became Chief Resident in the 2001-2002 academic year and proceeded into the two-year Vascular Surgery Fellowship at the University of Michigan the following year. Prior to joining the faculty at U-M, Dr. Eliason served as a Clinical Assistant Professor of Surgery at the University of Texas Health Science Center at San Antonio and as a staff surgeon for the San Antonio Military Vascular Surgery Service at Wilford Hall Medical Center and Brooke Army Medical Center. He was deployed to Balad, Iraq as a vascular surgeon in the 332nd Expeditionary Medical Group from 9/06 - 1/07 and was otherwise a member of the 859th Surgical Operations Squadron of the 59th Medical Wing at Lackland Air Force Base in Texas. He joined the faculty at the University of Michigan in the section of vascular surgery in 2007. Dr. Eliason is rated as an Experienced provider by MediFind in the treatment of Radiation Sickness. His top areas of expertise are Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Peripheral Artery Disease, Carotid Artery Surgery, and Aneurysm Repair.
U Of M Vascular Surgery
Katherine A. Gallagher, Professor of Surgery, Professor of Microbiology and Immunology and the Leland Ira Doan Research Professor of Vascular Surgery at U-M, is internationally known for her innovative translational research on epigenetic regulation of immune cells during normal and pathologic tissue repair and other cardiovascular disease processes. She is an expert in the molecular pathogenesis of wound repair and has contributed substantially to the understanding of epigenetics in immune cells associated with tissue repair, cardiovascular diseases, sepsis and most recently, COVID-19.She is, most notably, a member of the National Academy of Medicine, American Society of Clinical Investigation, American Surgical Association, Society of Clinical Surgery, a James IV International Scholar, a Distinguished Fellow of the Society of Vascular Surgery and a Taubman Scholar. Gallagher received a Bachelor of Science degree in physiology and neurobiology from the University of Maryland in 1998, graduating with Highest Honors. She was a Howard Hughes Fellow at the NIH for two years. She graduated summa cum laude from the University of Maryland School of Medicine in 2002. She pursued her general surgery training at the University of Maryland, followed by her vascular surgery training at Columbia University in New York. During her residency, she pursued a post-doctoral research fellowship at the University of Pennsylvania. She has been tenure track faculty at the University of Michigan since 2011. Dr. Gallagher is rated as an Experienced provider by MediFind in the treatment of Radiation Sickness. Her top areas of expertise are Arterial Insufficiency, Peripheral Artery Disease, Arterial Embolism, and Abdominal Aortic Aneurysm (AAA).
University Hospital
Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Radiation Sickness. His top areas of expertise are Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer.
Med Inn Building
Dr. Edwards is the James Hayward Endowed Clinical Professor of Oral & Maxillofacial Surgery and the Chief of Pediatric Oral and Maxillofacial Surgery, and Chair of Oral and Maxillofacial Surgery/Hospital Dentistry. He also serves as the chief of Pediatric Oral and Maxillofacial Surgery at C.S. Mott Children's Hospital. He graduated from the Dalhousie University School of Dentistry and the University of Michigan Medical School. Dr. Edwards completed his residency at the University of Michigan in Oral and Maxillofacial Surgery. After his residency, Dr. Edwards completed fellowship training at the University of Pittsburgh in Craniofacial Surgery and the University of Michigan in Oncology and Microvascular Reconstruction. Dr. Edwards' clinical interests include cleft lip and palate and craniofacial differences and pediatric head and neck oncology and survivorship. Dr. Edwards is rated as an Experienced provider by MediFind in the treatment of Radiation Sickness. His top areas of expertise are Osteochondroma, Cherubism, Prognathism, Osteotomy, and Myringotomy.
Rogel Cancer Center
Dr. Lesly Dossett, MD, MPH, is the Maud T. Lane Research Professor for Cancer Quality Improvement and Chief of the Division of Surgical Oncology at the University of Michigan. Dr. Dossett earned her medical degree from Vanderbilt University School of Medicine in 2003, having attended on a United States Navy Health Professions Scholarship. She completed her general surgery residency at Vanderbilt University in 2010, which included a health services research fellowship and completion of an MPH. After residency, Dr. Dossett served on active duty with the United States Navy in several roles stateside and overseas, including completing two deployments supporting combat operations in Afghanistan. After leaving the Navy in 2014, Dr. Dossett completed a clinical fellowship in Complex General Surgical Oncology at Moffitt Cancer Center and joined the faculty of the University of Michigan in 2016.Dr. Dossett specializes in treating patients with melanoma, soft tissue sarcoma, and breast cancer. Her research leverages implementation science frameworks and behavioral strategies to improve healthcare value. As co-director of the Michigan Program for Value Enhancement (MPrOVE), she works to translate value-based research findings into practice at Michigan Medicine and then scale those strategies more broadly to hospitals and healthcare systems. She is a principal investigator for R01s funded by the National Cancer Institute (NCI) and the Agency for Healthcare Research and Quality (AHRQ). She serves as a mentor on several federally funded training grants and career development awards.Dr. Dossett is an active member of several national societies. She serves as an officer in the Association for Academic Surgeons (AAS) and in the executive leadership of the American College of Surgeons (ACS) Cancer Research Program (CRP) and the Surgical Outcomes Club.Clinical Specialization:Dr. Dossett’s clinical focus is on melanoma and non-melanoma skin cancers, sarcoma, and breast cancer. She has expertise in locally and regionally advanced melanoma, breast angiosarcoma, retroperitoneal and pelvic sarcoma, breast conservation therapy, and skin and nipple sparing mastectomy. Dr. Dossett is rated as an Experienced provider by MediFind in the treatment of Radiation Sickness. Her top areas of expertise are Retroperitoneal Liposarcoma, Melanoma, Desmoplastic Small Round Cell Tumor, Mastectomy, and Lymphadenectomy.
Last Updated: 04/28/2026







